NovoLog FlexPen and Rituxan Hycela
Determining the interaction of NovoLog FlexPen and Rituxan Hycela and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Rituximab
- NovoLog FlexPen-Rituximab and Hyaluronidase
- NovoLog FlexPen-Rituximab and hyaluronidase human, recombinant Subcutaneous
- NovoLog FlexPen-Rituximab Intravenous
- NovoLog FlexPen-Riva-Amoxicillin
- NovoLog FlexPen-Rivaroxaban
- Rituxan Hycela-Novolog Injection
- Rituxan Hycela-NovoLog Mix 70/30
- Rituxan Hycela-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Rituxan Hycela-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Rituxan Hycela-NovoLog Mix 70/30 FlexPen
- Rituxan Hycela-NovoLog PenFill